Page 101 - AN-4-4
P. 101

Advanced Neurology                                                Diffusion model for brain tumor classification



            the model benefits significantly from the high-quality   same pre-processed dataset for consistent evaluation. The
            synthetic images generated using DDM. The stability of   comparison focused on key metrics, including accuracy,
            both sets of curves underscores the effectiveness of the   sensitivity, specificity, and F1 score. The performance of
            DDM-based data augmentation strategy in enhancing   each model is summarized in Table 4.
            model generalization and convergence. The learning
            progression reflects that the CDCNN model, when trained   4. Discussion
            on a combination of real and synthetic datasets, efficiently   The proposed CDCNN model, when combined with DDM
            captures the discriminative features of brain tumor classes.  for synthetic data augmentation, achieved a remarkable
            3.4. Performance metrics and receiver operating    classification accuracy of 96.2%, outperforming other
            characteristic analysis                            state-of-the-art architectures and prior works in the
                                                               field. This is a substantial improvement over the work by
            In addition to accuracy, sensitivity, specificity, F1 score,
            and model convergence/learning curves, the positive
            predictive value (PPV) and negative predictive value
            (NPV) were computed for each tumor class, as shown in
            Table 3. The CDCNN model achieved high PPV and NPV
            values across all tumor types, indicating a strong ability to
            correctly identify both positive and negative cases.
              The AUC values ranged from 0.962 to 0.991,
            underscoring the excellent discriminatory power of
            the model.  Figure  7 displays the receiver operating
            characteristic curves for each tumor class, showing high
            true positive rates and low false positive rates, consistent   Figure  6.  Training and validation loss curves illustrating stable and
                                                               decreasing trends, indicating effective model optimization
            with the high sensitivity and specificity metrics.
            3.5. Hexagonal radar chart visualization
            To provide a holistic view of the model’s performance
            across all key metrics—accuracy, sensitivity, specificity, F1
            score, PPV, and NPV—a hexagonal radar chart was plotted
            (Figure 8). This visualization allows for direct comparison
            of the balance between sensitivity and specificity, as
            well as the trade-off between precision and recall. The
            near-uniform shape and large coverage area in the chart
            demonstrate the consistent and balanced performance of
            the CDCNN model across metrics, compared to baseline
            models that show relatively irregular performance profiles.
            3.6. Comparative analysis of the CDCNN model with
            standard models
            To evaluate the performance of the CDCNN model, a
            comparative analysis was conducted against established   Figure  7. Receiver operating characteristic curves for brain tumor
                                                               classification across the four tumor classes: Glioma, meningioma,
            architectures:  ResNet50,  VGG16,  VGG19,  and     pituitary tumor, and no tumor. The areas under the curves represent 98%
            InceptionV3. These models were trained and tested on the   confidence intervals.

            Table 3. Expanded performance metrics on synthetic datasets

            Class         Precision (PPV [%])  Recall (sensitivity [%])  F1 score (%)  Specificity (%)  NPV (%)  AUC
            Glioma             89.0               91.0              90.0            96.3        95.8     0.964
            Meningioma         92.0               89.0              91.0            96.9        95.5     0.962
            Pituitary tumor    88.0               95.0              91.0            96.5        97.2     0.973
            No tumor           98.0               97.0              97.0            98.5        97.8     0.991
            Abbreviations: AUC: Area under the curve; NPV: Negative predictive value; PPV: Positive predictive value.


            Volume 4 Issue 4 (2025)                         95                           doi: 10.36922/AN025130025
   96   97   98   99   100   101   102   103   104   105   106